• Product NameElacridar
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityElacridar (GF120918) is a potent P-gp (MDR-1) and BCRP inhibitor.
• Target NameP-gp inhibitor
• CAS No. 143664-11-3
• Calculated MW 563.64
• Formulation C34H33N3O5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:COC1=CC=CC2=C1NC1=C(C=CC=C1C(=O)NC1=CC=C(CCN3CCC4=CC(OC)=C(OC)C=C4C3)C=C1)C2=O
  Pathways:Membrane transporter/Ion channel; Neuroscience
  Receptor:P-gp?(P-glycoprotein)
  Boling pt:
  Melting pt:216-218C
  Solubility:DMSO: 41 mg/mL (72.74 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Tang SC, et al. Int J Y. 2014, 134(6), 1484-1494.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting